Chimeric antigen receptor T‑cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges. (2021). Voprosy Onkologii, 67(3), 350-360. https://doi.org/10.37469/0507-3758-2021-67-3-350-360